The insulin/IGF system is a regulator of both normal39 and leukemic hematopoiesis.40 Because AML cells are exposed to insulin in vivo, we tested the effects of pathway inhibitors in the presence of this agonist. The gene discussed is IGF1; the disease is acute myeloid leukemia.